L-Glutamate has a distinctive taste, known as "umami," that is neither sweet, sour, salty, nor bitter (24) , and it is widely used as a flavor enhancer. About 1.8 million tons of monosodium glutamate are produced worldwide per year by fermentation using coryneform bacteria. These are rod-shaped, nonsporulating, gram-positive bacteria containing mycolic acids and are widely distributed in the natural world. A nonpathogenic species, Corynebacterium glutamicum, was originally isolated as an L-glutamate-producing bacterium (12, 34) . Wild-type C. glutamicum, without breeding, releases more than 80 g/liter of L-glutamic acid under appropriate culture conditions (27) .
The mechanism of L-glutamate secretion by C. glutamicum is unique. The presence of biotin, which is required by C. glutamicum for growth, inhibits L-glutamate production in the culture medium, while production is induced under biotinlimiting conditions (26) and in response to fatty acid ester surfactants (31) and penicillin (22) . It is also induced by ethambutol treatment, which inhibits formation of the mycolic acid layer of the cell wall (25) . Since biotin limitation and the other inducing treatments cause damage to cell surface structures of this microorganism, it has long been assumed that L-glutamate leaks through the cell membrane (32) .
The dtsR1 gene, isolated as a multicopy suppressor of a mutant hypersensitive to fatty acid ester surfactants, encodes a protein showing strong homology to the ␤ subunit of acetylcoenzyme A (CoA) carboxylase (10) . Since biotin is a cofactor of acetyl-CoA carboxylase, biotin limitation, like treatment with fatty acid ester surfactants, might affect the biotin-enzyme complex containing DtsR1. Overexpression of cls, encoding cardiolipin synthase, or acp, encoding acyl carrier protein, also results in trigger-independent glutamate secretion (18) . Penicillin inhibits cell wall biosynthesis by binding to penicillinbinding proteins, which catalyze the transglycosylation and transpeptidation of peptidoglycan. C. glutamicum is highly tolerant to lysis by lytic enzymes, such as egg white lysozyme, that catalyze hydrolysis of the ␤-1,4 glycoside bond between Nacetylglucosamine and N-acetylmuramic acid of peptidoglycan. Mutation of the ltsA gene, which encodes a putative glutaminedependent amidotransferase that is involved in the formation of rigid cell wall structure, leads to production of glutamate, but the connection between cell wall biosynthesis and L-glutamate secretion remains unclear (5) .
The activity of the 2-oxoglutarate dehydrogenase complex (ODHC) reportedly decreases during L-glutamate production in response to biotin limitation, fatty acid ester surfactants, and penicillin (8) . Since ODHC is located at the branch point between the tricarboxylic acid (TCA) cycle and L-glutamate biosynthesis, a decrease in ODHC activity could switch the metabolic flow from the TCA cycle to L-glutamate synthesis. The ODHC generally comprises three enzymes: 2-oxoglutarate dehydrogenase (E1o), dihydrolipoamide S-succinyltransferase (E2o), and dihydrolipoamide dehydrogenase (E3). Disruption of odhA, which encodes the E1o subunit, results in L-glutamate secretion without induction (1) . Metabolic linkage between acetyl-CoA carboxylase and ODHC might trigger L-glutamate secretion, since a dtsR1 disruptant (see above) produced a significant amount of L-glutamate and exhibited reduced ODHC activity (11) . Recently a novel form of ODHC activity regulation in C. glutamicum was reported (20) : ODHC activity was strongly inhibited by the nonphosphorylated form of the OdhI protein, which is phosphorylated by the serine/threonine protein kinase PknG.
In the past decade, our understanding of the molecular basis of amino acid secretion has enabled the identification of the lysE, thrE, and brnFE genes, which encode novel carriers exporting L-lysine, L-threonine, and L-isoleucine, respectively (9, 28, 35) . Although it has been suggested that secretion of Lglutamate by biotin-limited cells of C. glutamicum is mediated by a carrier system in the plasma membrane, no L-glutamate exporter has yet been identified (7) .
Here we show that the product of a C. glutamicum NCgl1221 gene is homologous to mechanosensitive channels and plays an important role in L-glutamate secretion, and we propose a new model for the induction of L-glutamate secretion. (17) was used as a nonreplicating integration vector. pBS4S was constructed by ligating the PCR-amplified sacB gene of Bacillus subtilis to pHSG299 (TAKARA BIO Inc., Shiga, Japan) cleaved with AvaII, and the SmaI recognition site in the kanamycin-resistant gene was destroyed by nucleotide substitution using crossover PCR without a change of amino acid residue. Plasmid pVK9 (17) , derived from pHM1519 (16) , was used to construct a genomic library.
MATERIALS AND METHODS

Bacterial
Construction of mutants. To disrupt the odhA gene, an internal fragment of odhA was generated by PCR with the primer pair 5Ј-GGG GAT CCA TCG GTA TGC CAC ACC GTG GTC GCC-3Ј and 5Ј-GGG GAT CCA CGA CTG CTT CTG CAT CTT CGT TGG-3Ј (underlining indicates BamHI restriction site), using ATCC 13869 chromosomal DNA as a template. The amplified fragment was cleaved with BamHI and ligated to BamHI-cleaved pBS4S, resulting in pBS4odhAint. This plasmid, which lacks a functional replication origin in C. glutamicum, was introduced into ATCC 13869 by electroporation. Integration of the plasmid into the chromosomal odhA gene was verified by PCR.
To construct BL1 [NCgl1221(V419::IS1207)], a NCgl1221 gene fragment was amplified by PCR with the primer pair 5Ј-GGG AGC TCG ACT TTC TGG CTC CTT TAC T-3Ј and 5Ј-GGG AGC TCG CCG ATG ACT AAT AAT GAG A-3Ј (underlining indicates SacI restriction site), using the C. glutamicum 2A-1R chromosome as a template. The fragment was cleaved with SacI and ligated to SacI-cleaved pBS4S, yielding pBSo15832A-1.
To construct BL2 [NCgl1221(A111V)] and BL3 [NCgl1221(W15CSLW)], NCgl1221 gene fragments were amplified by PCR with the primer pair 5Ј-GGG AGC TCG ACT TTC TGG CTC CTT TAC T-3Ј and 5Ј-GGG AGC TCC ACG GCA TGC CGA CCA CCG T-3Ј (underlining indicates SacI restriction site), using the C. glutamicum odhA mutant L30-2 or A1 chromosome as a template. The fragment was digested with SacI and ligated to SacI-cleaved pBS4S, yielding pBS4S1583L30 and pBS4S1583A1, respectively.
The NCgl1221 gene disruptant pBS4⌬NCgl1221 was constructed by two successive rounds of PCR. In the first round, one-half of the fragment was amplified using the chromosomal DNA of ATCC 13869 as a template and the primer pair 5Ј-GGG AGC TCA CCT TTG TGG AGG AAT AGA G-3Ј (underlining indicates a SacI restriction site) and 5Ј-GGG ACA CGT CTG TAA TCA GCG TCC TAG AGC CAA GAT TAG CGC TGA A-3Ј, while the other half was amplified with the primer pair 5Ј-TTC AGC GCT AAT CTT GGC TCT AGG ACG CTG ATT ACA GAC GTG TCC C-3Ј and 5Ј-GGG AGC TCA GTA CTC TTC CTT GGA CAT C-3Ј (underlining indicates a SacI restriction site). In the second round, the resulting products were mixed in a 1:1 molar ratio and subjected to PCR using the following primer pair: 5Ј-GGG AGC TCA CCT TTG TGG AGG AAT AGA G-3Ј and 5Ј-GGG AGC TCA GTA CTC TTC CTT GGA CAT C-3Ј (underlining indicates SacI restriction sites). The amplified product was digested with SacI and ligated with SacI-digested pBS4S, giving pBS4⌬NCgl1221.
Each plasmid was introduced into C. glutamicum ATCC 13869, and clones with the plasmid integrated into the NCgl1221 gene were selected for further use.
Enzyme preparation and assay. All steps were performed at 4°C. C. glutamicum cells were harvested, washed twice in 0.2% KCl, and suspended in 100 mM N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid-NaOH buffer, pH 7.5, containing 30% glycerol. Cells were disrupted by sonication, and the cellular debris was removed by centrifugation (15,000 ϫ g for 15 min). The crude enzyme extracts were gel filtered in the same buffer on PD10 columns (GE Healthcare Bio-Science Corp., Piscataway, NJ) to remove intracellular metabolites. ODHC activity was measured at 30°C in a photometric assay by following the initial rate in absorbance of 3-acetylpyridine adenine dinucleotide at 365 nm. The standard reaction mixture contained 100 mM N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid-NaOH buffer, pH 7.7, 0.2 mM CoA, 0.3 mM thiamine pyrophosphate, 1 mM sodium 2-oxoglutarate, 3 mM L-cysteine, and 5 mM MgCl l2 . A control experiment was performed without sodium 2-oxoglutarate. 1 HCl, 300 g biotin, 13.8 ml soybean protein hydrolysate (total nitrogen, 0.48 g), 50 g CaCO 3 (separately sterilized) adjusted to pH 8.0 with KOH] in 500-ml Sakaguchi flasks with shaking. For fatty acid ester surfactant or penicillin treatments, cells were cultured in 20 ml GH2 medium [GH1 medium but with 80 g glucose, 30 g (NH 4 ) 2 SO 4 , and 60 g biotin] in 500-ml Sakaguchi flasks with shaking until the glucose was completely consumed. Aliquots (2 ml) of these cultures were inoculated into 20 ml GH2 medium. When the optical density at 620 nm (OD 620 ) reached about 20, Tween 40 or penicillin G was added to a final concentration of 5 mg/ml or 0.4 U/ml, respectively. For L-glutamate fermentation by biotin depletion, 2-ml aliquots of cell culture were inoculated into 20 ml GH3 medium (GH2 medium without biotin).
For L-glutamate fermentation in a jar fermentor, cells were grown in 300 ml GH4 medium (per liter, 60 g glucose, 1. For the main fermentation, 30-ml aliquots of cell culture were inoculated into 270 ml GH5 medium (per liter, 111 g glucose, 3.84 g KH 2 PO 4 , 1.11 g MgSO 4 ⅐ 7H 2 O, 0.011 g FeSO 4 ⅐ 7H 2 O, 256 g vitamin B 1 HCl, 11 ml soybean protein hydrolysate [total nitrogen, 0.39 g]). Aeration was controlled by agitation to keep the dissolved oxygen level above 5%. All cells were cultured at 31.5°C. The pH was maintained at 7.2 with ammonia gas.
Extraction of intracellular metabolites. Extraction of intracellular metabolites was performed by a modification of the method previously described (29) . Cells were separated from the medium by rapid vacuum filtration (Durapore HV, 0.45 m; Millipore, Billerica, MA), followed by two washes with 10 ml MilliQ water and incubation of the filter and attached cells for 10 min in 2 ml methanol containing 5 M morpholineethanesulfonic acid and 5 M methionine sulfone. The extract (1.6 ml) was mixed with 1.6 ml CHCl 3 and 640 l MilliQ water, and the aqueous phase was applied to a spin column to remove protein contamination (Ultrafree-MC; Millipore). The filtered extracts were analyzed using capillary electrophoresis mass spectrometry by Human Metabolome Technologies Inc. (Yamagata, Japan). The cell volume used to calculate intracellular metabolite concentrations was 1.6 l mg Ϫ1 dry cell weight (DCW) (4). The DCW was calculated from the OD 620 by the following experimentally obtained formula: DCW ϭ 22.707 ϫ (OD 620 )/100 (g liter Ϫ1 ).
by homologous recombination between the chromosomal odhA gene and a truncated odhA gene. The plasmid pBS4odhAint, which carries an internal fragment of the odhA gene of C. glutamicum, was introduced into wild-type C. glutamicum ATCC 13869 cells and kanamycin-resistant transformants selected, which should harbor the plasmid integrated into the host chromosome by homologous recombination at the odhA locus. The resultant odhA-disrupted strains had extremely unstable phenotypes, forming colonies of various sizes on CMDex agar plates. We cultured several odhA-disrupted clones in liquid GH1 medium and analyzed the metabolites in the culture broth. Most clones produced 2-oxoglutarate, lactate, acetate, and pyruvate but not L-glutamate; however, clone 2A-1 produced high levels of L-glutamate in the presence of excess biotin. In order to determine whether 2A-1 had gained an additional mutation(s) that rendered it an L-glutamate producer, its wildtype odhA gene was restored by homologous recombination using pBS4odhAint. The odhA mutants grew very poorly on medium without sugar because their energy generation depended primarily on glycolysis. Hence, we grew cells of strain 2A-1 on CM2B plates without sugar to cure the plasmid and selected a clone that formed larger colonies. Curing of the plasmid and restoration of the wild-type odhA gene were confirmed by PCR and sequencing as well as measuring of ODHC activity: the odhA ϩ revertant, named 2A-1R, and the wild-type strain had specific ODHC activities of 1.8 Ϯ 0.5 and 3.7 Ϯ 1.0 nmol min Ϫ1 (mg protein) Ϫ1 , respectively, while 2A-1 had no detectable ODHC activity.
The L-glutamate productivity of this odhA ϩ clone was examined. As expected, 2A-1R retained the ability to produce Lglutamate in the presence of excess biotin (Fig. 1) . The rates of L-glutamate production were almost the same in 2A-1 (odhA) and 2A-1R (odhA ϩ ), but the maximum yield of 2A-1R was slightly lower than that of 2A-1. The L-glutamate produced by 2A-1R was assimilated after the glucose had been completely consumed. Since the ability to assimilate L-glutamate depends on ODHC activity, this indirectly confirmed restoration of ODHC activity in 2A-1R. These findings show that odhA disruption does not confer the ability to produce L-glutamate efficiently. Rather, 2A-1 carries an unknown mutation(s) that independently confers the ability to produce L-glutamate.
Identification of a mutation in strain 2A-1R inducing Lglutamate production. Growth of 2A-1R was slow on minimal medium, probably because the substrate (glucose) is used not only for growth but also for L-glutamate production. Based on this observation, we shotgun cloned a gene capable of restoring the growth of 2A-1R on minimal medium. A Sau3AI library of wild-type C. glutamicum chromosomal DNA, constructed in the E. coli-C. glutamicum shuttle vector pVK9, was introduced into 2A-1R by electroporation, and transformants that grew faster on minimal medium plates were selected. From these we isolated a plasmid, designated pL5k, that abolished L-glutamate production and restored rapid growth on minimal medium. Sequencing of a 3-kb Sau3AI fragment from the plasmid showed that it contained only one intact gene, NCgl1221. The 533-amino-acid product of this gene has previously been reported to catalyze betaine efflux (21) . Its deduced amino acid sequence has significant homology to mechanosensitive ion channels, such as the E. coli yggB gene product. Mechanosensitive channels are gated by alterations of membrane tension, thus preventing cell disruption by hypo-osmotic shock (13, 30) . The NCgl1221 protein has an N-terminal region similar to that of YggB and an additional C-terminal region unlike any known sequence. This type of protein is also present in other corynebacteria, such as C. glutamicum ATCC 13032, Corynebacterium efficiens YS314, Corynebacterium diphtheriae NCTC 13129, and Corynebacterium jeikeium K411 (GenBank accession no. NC_004369, NC_004369, NC_002935, and CR931997, respectively).
The coding region of the endogenous NCgl1221 gene of 2A-1R was found to contain an insertion sequence with 99.9% identity to IS1207 at nucleotide 1258, resulting in the production of a C-terminally truncated NCgl1221 protein of 423 amino acids. To determine whether this mutation was responsible for L-glutamate production, we cloned the mutant NCgl1221 gene [named NCgl1221(V419::IS1207)] and introduced it into wild-type C. glutamicum ATCC 13869. The cloning process requires integration into the chromosome by ho- In the course of constructing BL1, we obtained an integrant carrying both wild-type NCgl1221 and NCgl1221 (V419::IS1207). The L-glutamate productivity of this integrant was one-fourth that of BL1 under biotin-sufficient conditions (data not shown). It is therefore possible that the NCgl1221 gene product forms oligomers, like E. coli YggB, which is predicted to form hexamers (30) , and that therefore NCgl1221(V419::IS1207) is semidominant. This might explain the ability of the wild-type NCgl1221 gene cloned in the multicopy plasmid to restore the growth of 2A-1R on minimal medium and reduce its L-glutamate productivity.
We also sequenced the NCgl1221 genes of other odhA disruptants of C. glutamicum that produce large amounts of L-glutamate. As expected, most had mutations in the NCgl1221 gene. Substitutions identified were Ala1003Thr [named NCgl1221 (A100T)], Ala1113Val [NCgl1221(A111V)], Ala1113Thr [NCgl1221(A111T)], Pro4243Leu [NCgl1221(P424L)], and Trp153Cys-Ser-Leu-Trp [insertion of three amino acids; NCgl1221(W15CSLW)]. odhA disruptants that produced very little or no L-glutamate carried the wild-type NCgl1221 allele. The PHDhtm program (http://www.predictprotein.org/newwebsite /submit.html) predicts that NCgl1221 has three transmembrane segments in its N-terminal domain and one transmembrane segment in its C-terminal domain. The NCgl1221(W15CSLW), NCgl1221(A100T), NCgl1221(A111T), and NCgl1221(A111V) substitutions are located in the N-terminal domain, while the NCgl1221(V419::IS1207) and NCgl1221(P424L) substitutions are in the C-terminal domain (Fig. 2a) .
E. coli yggB mutations have been described that confer constitutive K ϩ leakage phenotypes in the absence of hypo-osmotic shock, so-called gain-of-function (GOF) mutations (15, 23) . Two GOF mutations of E. coli YggB have substitutions, A102P and L109S, respectively, in the third transmembrane helix (Fig. 2b) . The positions of NCgl1221(A100T) and probably of NCgl1221(A111V) and NCgl1221(A111T) in the third transmembrane helix resemble these substitutions, suggesting that alterations in this region cause a structural transformation, producing the GOF phenotype: constitutive excretion of Lglutamic acid. The NCgl1221(V419::IS1207) and NCgl1221 (P424L) substitutions in the C-terminal region also cause a GOF-like phenotype. In particular, NCgl1221(V419::IS1207) results in truncation of the C-terminal extracellular domain, suggesting that changes in this region can also produce alterations of the structure of the NCgl1221 protein, leading to L-glutamic acid excretion.
We constructed NCgl1221(A111V) and NCgl1221(W15CSLW) derivatives of wild-type C. glutamicum by replacing the NCgl1221 gene on the chromosome. These NCgl1221 gene mutants, designated BL2 and BL3, respectively, also produced remarkably high levels of L-glutamate without induction ( Table  1 ), confirming that NCgl1221 gene mutations on their own cause L-glutamate overproduction.
NCgl1221 gene mutations render cells resistant to the Lglutamate analog, 4-fluoroglutamate. Overexpression of the E. coli arginine exporter YggA renders cells resistant to canavanine, an arginine analog that inhibits cell growth (19) . We therefore examined the effect of NCgl1221 gene mutations on sensitivity to an L-glutamate analog. As shown in Fig. 3a , the NCgl1221(A111V) and NCgl1221(W15CSLW) strains grew faster than the wild type on minimal medium containing 4-fluoroglutamic acid. The colony-forming efficiency of the wildtype strain was only 3.2% in the presence of 1.25 mM 4-fluoroglutamic acid, while those of the NCgl1221(A111V) and NCgl1221(W15CSLW) strains were 46% and 60%, respectively (Fig. 3b) . These data imply that the mutant NCgl1221 proteins reduce 4-fluoroglutamic acid entry. However, amplification of the wild-type NCgl1221 gene did not affect 4-fluoroglutamic acid sensitivity (data not shown). We speculate that the glutamate export system of wild-type C. glutamicum is inactive under normal growth conditions and that it is activated by conformational changes of NCgl1221 caused by certain Effect of NCgl1221 gene amplification on L-glutamate production. The amplification of an amino acid exporter gene is expected to increase excretion of the corresponding amino acid. For example, amplification of the lysE gene encoding the lysine exporter leads to excretion of L-lysine, although a large amount of L-lysine is not excreted by the wild-type strain without treatments to increase the intracellular L-lysine pool (35) . It is reported that most amino acid exporters are regulated by intracellular metabolite concentrations. Thus, lysE expression is positively regulated by the transcriptional regulator LysG, which senses the intracellular L-lysine pool (2) . brnFE, encoding the L-methionine/L-isoleucine exporter, is also positively regulated by intracellular L-methionine and L-isoleucine levels (33) .
We examined the effects of amplifying the NCgl1221 gene on L-glutamate production. The resultant strain produced no L-glutamic acid in the presence of excess biotin; however, when induced by biotin limitation, it produced larger amounts of L-glutamic acid than the wild type (Table 2) . Similar results were obtained using other induction conditions, such as Tween 40 or penicillin treatment. Under these conditions, the times required for L-glutamate production to reach plateaus were almost identical (data not shown), although the biomass yield of the NCgl1221 gene-amplified strain was reduced. This means that the L-glutamate secretion rate per cell was increased by NCgl1221 gene amplification. It is also suggested that L-glutamate export is activated by the NCgl1221 protein only under conditions that induce L-glutamate production.
Effects of NCgl1221 gene disruption on L-glutamate production. If the NCgl1221 protein is the major L-glutamate exporter of C. glutamicum, L-glutamate production should be diminished by disrupting the NCgl1221 gene. We deleted the chromosomal NCgl1221 locus and tested the resulting NCgl1221 gene disruptant for L-glutamate productivity in limiting biotin. L-Glutamate production and the glucose consumption rate were both greatly diminished (Fig. 4) . After 8 h of cultivation, L-glutamate accumulation in the wild type and the NCgl1221 gene disruptant reached 66.6 mM and 12.2 mM, respectively. The intracellular L-glutamate levels of the wild type and the NCgl1221 gene disruptant decreased gradually from the nonproducing period to the producing period. Although the wild type and the NCgl1221 gene disruptant had similar levels of intracellular L-glutamate in the nonproducing period, intracellular L-glutamate in the disruptant was about 4-to 10-fold higher than that of the wild type during the producing period. We also examined other metabolites. L-Aspartate behaved similarly to L-glutamate. Extracellular L-aspartate was lower in the disruptant than in the wild type, while the reverse was true of intracellular L-aspartate. By contrast, the ratio of intracellular 2-oxoglutarate to extracellular 2-oxoglutarate was almost the same in the wild type and disruptant (data not shown). Similar results were obtained when the L-glutamate production was induced with Tween 40 or penicillin treatment: the amount of L-glutamate after 24 h of cultivation was 6.8-fold or 7.1-fold lower in the disruptant than that in the wild type, respectively. These results suggest that the NCgl1221 protein is the major exporter of the acidic amino acids L-glutamic acid and L-aspartic acid in C. glutamicum. An alternative possibility is that it is a positive regulator that activates an acidic amino acid export system in response to those treatments that induce L-glutamate excretion.
DISCUSSION
Amplification of biosynthesis genes, attenuation of biosynthetic branch points, and interference with feedback inhibition and repression have been used to improve amino acid production for more than 50 years. However, although their existence was assumed, genes controlling amino acid export, such as the exporter gene for L-lysine, have only recently been identified. It is reported that expression of exporter genes is induced by an increase in the intracellular pool of the corresponding amino acid (2, 33) . If the L-glutamate exporter of C. glutamicum were regulated by the intracellular L-glutamate pool, ODHC disruptants should be provoked by increases in the 2-oxoglutarate pool to produce significant amounts of L-glutamate and so to induce the expression of the L-glutamate exporter. However, as described above, ODHC disruptants do not produce large amounts of L-glutamate. This suggests that L-glutamate export activity is not induced by increases in intracellular L-glutamate.
We showed that the L-glutamate-overproducing odhA disruptants that we isolated also carry a NCgl1221 gene mutation. The N-terminal region of the NCgl1221 protein is similar to the mechanosensitive channels of other microorganisms. It is thought that these channels are activated by alteration of membrane tension (13, 30) . By contrast, the C-terminal region of NCgl1221 does not resemble that of any known protein. From the results reported in this study, we conclude that NCgl1221 is the major exporter of L-glutamic acid in C. glutamicum and that it is activated by alterations of membrane tension. Treatments inducing L-glutamate production, such as biotin limitation and addition of Tween 40 or penicillin, alter membrane tension by inhibiting lipid or peptidoglycan biosynthesis and lead to excretion of L-glutamic acid by activating NCgl1221. The NCgl1221 gene mutations found in some of the ODHC mutants probably also produce structural changes in NCgl1221 that lead to the constitutive export of L-glutamate without any change in membrane tension. Similar constitutively active mutations, so-called "gain-of-function" mutations, have been reported in E. coli yggB (15, 23) .
We observed that the intracellular L-glutamate pool under L-glutamate-producing conditions was lower than under nonproducing conditions, as previously described (6) . Were attenuation of ODHC activity to trigger L-glutamate production, intracellular L-glutamate would be elevated. In order to explain a decrease in the L-glutamate pool under L-glutamate-producing conditions, it would be necessary to suppose that L-glutamate biosynthesis is downregulated or that L-glutamate export is upregulated. However, ODHC activity is reduced and GDH activity unchanged under L-glutamate-producing conditions (8) . Therefore, we surmise that activation of the L-glutamate exporter is needed to trigger L-glutamate production (3, 4) .
We propose the following model for L-glutamate production. (i) Treatments leading to L-glutamate production cause changes in membrane tension. (ii) The structure of NCgl1221 is altered by these changes. (iii) Activated NCgl1221 catalyzes L-glutamate excretion (Fig. 5) .
Since the NCgl1221 gene disruptant still produced small but significant amounts of L-glutamate, a second minor L-glutamate export carrier may exist. It is also possible that the NCgl1221 protein is an activator of an L-glutamate exporter(s). If so, L-glutamate secretion by the unknown carrier must decrease fivefold in the absence of NCgl1221. It is reported that ATP or some related high-energy metabolite is required for L-glutamate secretion (4), but there is no ATP-binding motif in the NCgl1221 sequence. Hence, NCgl1221 may activate a putative L-glutamate exporter driven by ATP or a related highenergy metabolite under L-glutamate secretion conditions. Measurements of intracellular metabolites in the NCgl1221 gene disruptant suggest that the NCgl1221 export system exports both L-glutamate and L-aspartate but not 2-oxocarboxylic acids, such as 2-oxoglutarate.
Treatments that induce L-glutamate production also cause a decrease in ODHC activity, resulting in an increase in the intracellular L-glutamate concentration, potentially mediated by the OdhI-PknG system (20) . The ODHC activity of 2A-1R carrying a mutant NCgl1221 gene decreased twofold compared with that of the wild-type strain, suggesting that the NCgl1221 gene mutations affect ODHC activity. This attenuation of ODHC activity further increases production of L-glutamate only when the NCgl1221 exporter is activated. Since a decrease in ODHC activity was also observed in response to treatments that induce L-glutamate secretion, the activated forms of NCgl1221 may affect ODHC activity. This might be mediated by the OdhI-PknG system. Why do C. glutamicum cells excrete large amounts of Lglutamate when exposed to induction treatments? Since these treatments all affect cell surface structures and may therefore alter membrane tension, L-glutamate may function as a compatible solute to prevent cells from bursting. Another potential function of L-glutamate excretion is carbohydrate storage during periods when sugar is in excess and cell growth is inhibited by the absence of biotin. The excreted L-glutamate might then be used as a carbon source when biotin becomes available once more. Thus, L-glutamate production by C. glutamicum may be a mechanism of adaptation to environmental changes affecting cell surface structures. 
